Onderneming DermTech, Inc.
Aandelen
DMTK
US24984K1051
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,702 USD | -0,99% | -1,40% | -59,89% |
07/03 | DERMTECH, INC. : BTIG herhaalt koopadvies | ZM |
05/03 | DERMTECH, INC. : Stephens Inc. handhaaft het Neutraal advies | ZM |
Vakgebied
Aantal werknemers: 207
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
DermTech Melanoma Test
94,0
%
| 14 | 95,0 % | 14 | 94,0 % | +4,31% |
Smart Stickers
3,9
%
| 0 | 1,0 % | 1 | 3,9 % | +289,47% |
Ribonucleic Acid Extractions
1,5
%
| 0 | 1,8 % | 0 | 1,5 % | -11,88% |
Project Management
0,6
%
| 0 | 2,2 % | 0 | 0,6 % | -71,43% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 15 | 100,0 % | 15 | 100,0 % | +5,36% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bret Christensen
CEO | Chief Executive Officer | 53 | 08-05-23 |
Kevin Sun
DFI | Director of Finance/CFO | 46 | 01-08-19 |
Steven Stone
CTO | Chief Tech/Sci/R&D Officer | - | 28-07-22 |
Compliance Officer | - | 28-07-22 | |
Loren Clarke
CTO | Chief Tech/Sci/R&D Officer | - | 16-06-21 |
Burkhard Jansen
CTO | Chief Tech/Sci/R&D Officer | 58 | 03-09-19 |
Steve Kunszabo
IRC | Investor Relations Contact | - | - |
Mark Aguillard
PRN | Corporate Officer/Principal | - | 19-09-23 |
Rachel Williams
HRO | Human Resources Officer | - | 01-08-20 |
Ray Akhavan
LAW | General Counsel | 55 | 05-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kirk Malloy
BRD | Director/Board Member | 58 | 18-07-22 |
Mark Capone
BRD | Director/Board Member | 61 | 18-07-22 |
Cynthia Collins
BRD | Director/Board Member | 65 | 03-09-19 |
Matthew Posard
CHM | Chairman | 56 | 01-07-16 |
Herm Rosenman
BRD | Director/Board Member | 76 | 01-01-17 |
Bret Christensen
CEO | Chief Executive Officer | 53 | 08-05-23 |
Nathalie Keraudy
BRD | Director/Board Member | 45 | 01-10-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 34 524 677 | 0 | 0 | 47,95 % |
Aandeel B | 1 | 34 623 443 | 33 154 660 ( 95,76 %) | 0 |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-59,89% | 24,31 mln. | |
+1,64% | 13,05 mld. | |
-13,95% | 7,32 mld. | |
-4,01% | 5,15 mld. | |
-0,04% | 4,58 mld. | |
-32,93% | 4,47 mld. | |
+0,39% | 4,27 mld. | |
+16,88% | 2,85 mld. | |
+3,24% | 2,55 mld. | |
+11,39% | 1,92 mld. |
- Beurs
- Aandelen
- Aandeel DermTech, Inc. - Nasdaq
- Onderneming DermTech, Inc.